Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
West Nile Virus
FDA approves Roche's cobas babesiosis test for blood donations
By
LabPulse.com staff writers
The in vitro screening test is designed for use with the company's 6800/8800 systems. Roche noted that the test is compliant with May 2019 guidance from the FDA regarding screening and testing blood donations for Babesia microti, a tick-borne, microscopic parasite that infects red blood cells.
September 19, 2019
Page 1 of 1
